Top Insider Buys Highlight for the Week of Feb. 1

GuruFocus.com
0
In this article:

- By Shuda Xia

The largest Insider Buys this week were for Delta Air Lines Inc. (DAL), DISH Network Corp. (DISH), IBERIABANK Corp. (IBKC), and PTC Therapeutics Inc. (PTCT).

Delta director bought 5,185 shares

Director Francis S. Blake bought 5,185 shares of Delta on Jan. 28 for an average price of $48.17 per share. The stock price has increased 3.63% since then.


Delta is a major American airline, operating over 5,400 flights daily. The company has a market capitalization of $34.23 billion; as of Feb. 1, it traded at $49.92.

On Jan. 15, the company reported fourth-quarter and full-year 2018 results. GAAP pretax income for the quarter was $1.3 billion, while net income was $1 billion and earnings per diluted share were $1.49. Adjusted net income for the quarter was $890 million while full-year GAAP pretax inome was $5.2 billion.

DISH Network executive vice president bought 35,000 shares

Executive Vice President James Defranco bought 15,000 shares for an average price of $29.6 per share. Since then, the stock price has increased 2.84%.

The American satellite and television company focuses on direct-broadcast satellite services. DISH has a market capitalization of $14.24 billion; as of Feb. 1, it traded at $30.44.

On Dec. 13, the company announced it will join the Comscore Campaign Ratings beta alongside other media companies.

IberiaBank director bought 2,500 shares

Director Ricky E. Maples bought 2,500 shares of IberiaBank on Jan. 29 for an average price of $75.6 per share. The stock price has decreased 1.81% since then.

The bank holding company has over 250 offices in 10 states and is a Russell 2000 component. The company has a market capitalization of $4.07 billion; as of Feb. 1, it traded at $74.23.

On Jan. 25, IberiaBank reported financial results for the fourth quarter ended Dec. 31. Net income was $129.1 million, or $2.32 per common share. GAAP return on average assets for 2018 was 1.25%, compared to 0.58% in the prior year. Reported and cash net interest margins improved 7 and 5 basis points on a linked quarter basis to 3.81% and 3.52%.

PTC Therapeutics director bought 66,225 shares

Director Michael Schmertzler bought 66,225 shares of PTC on Jan. 25 for an average price of $30.2.Since then, the stock price has increased 2.38%.

PTC Therapeutics is an American pharmaceutical company that focuses on the development of orally administered drugs that regulate gene expression by targeting post-translational control mechanisms. The company has a market capitalization of $1.8 billion; as of Feb. 1, it traded at $30.92.

On Jan. 23, the company announced the pricing of a public offering of 6,720,000 shares of its common stock at an offering price of $30.20 per share before underwriting discounts. The company has also granted the underwriter the option of purchasing up to an additional 1,008,000 shares of common stock. It closed the offering on Jan. 25.

For the complete list of stocks bought by company executives, go to Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.

This article first appeared on GuruFocus.


Advertisement

Recommended Stories